skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: assunto: Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells

JORDAN, C. T ; UPCHURCH, D ; LUGER, S. M ; PHILLIPS, G. L ; SZILVASSY, S. J ; GUZMAN, M. L ; HOWARD, D. S ; PETTIGREW, A. L ; MEYERROSE, T ; ROSSI, R ; GRIMES, B ; RIZZIERI, D. A

Leukemia, 2000-10, Vol.14 (10), p.1777-1784 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
2
Radiation dose selection in Hodgkin’s disease patients with large mediastinal adenopathy treated with combined modality therapy
Radiation dose selection in Hodgkin’s disease patients with large mediastinal adenopathy treated with combined modality therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radiation dose selection in Hodgkin’s disease patients with large mediastinal adenopathy treated with combined modality therapy

Elconin, Joel H ; Roberts, Kenneth B ; Rizzieri, David A ; Vermont, Carmen ; Clough, Robert W ; Kim, Charlotte ; Dodge, Richard K ; Prosnitz, Leonard R

International journal of radiation oncology, biology, physics, 2000-11, Vol.48 (4), p.1097-1105 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Monoclonal Antibody Therapy in the Treatment of Non-Hodgkin Lymphoma
Monoclonal Antibody Therapy in the Treatment of Non-Hodgkin Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Monoclonal Antibody Therapy in the Treatment of Non-Hodgkin Lymphoma

McCune, Steven L ; Gockerman, Jon P ; Rizzieri, David A

JAMA : the journal of the American Medical Association, 2001-09, Vol.286 (10), p.1149-1152 [Periódico revisado por pares]

Chicago, IL: American Medical Association

Texto completo disponível

Citações Citado por
4
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells

Guzman, Monica L. ; Neering, Sarah J. ; Upchurch, Donna ; Grimes, Barry ; Howard, Dianna S. ; Rizzieri, David A. ; Luger, Selina M. ; Jordan, Craig T.

Blood, 2001-10, Vol.98 (8), p.2301-2307 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Burkitt lymphoma arising in organ transplant recipients: A clinicopathologic study of five cases
Burkitt lymphoma arising in organ transplant recipients: A clinicopathologic study of five cases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Burkitt lymphoma arising in organ transplant recipients: A clinicopathologic study of five cases

GONG, Jerald Z ; STENZEL, Timothy T ; BENNETT, Ellen R ; LAGOO, Anand S ; DUNPHY, Cherie H ; MOORE, Joseph O ; RIZZIERI, David A ; TEPPERBERG, James H ; PAPENHAUSEN, Peter ; BUCKLEY, Patrick J

The American journal of surgical pathology, 2003-06, Vol.27 (6), p.818-827 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
6
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: Final results of cancer and leukemia group B study 9251
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: Final results of cancer and leukemia group B study 9251
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: Final results of cancer and leukemia group B study 9251

RIZZIERI, David A ; JOHNSON, Jeffrey L ; CANELLOS, George P ; LARSON, Richard A ; NIEDZWIECKI, Donna ; LEE, Edward J ; VARDIMAN, James W ; POWELL, Bayard L ; BARCOS, Maurice ; BLOOMFIELD, Clara D ; SCHIFFER, Charles A ; PETERSON, Bruce A

Cancer, 2004-04, Vol.100 (7), p.1438-1448 [Periódico revisado por pares]

New York, NY: Wiley-Liss

Texto completo disponível

Citações Citado por
7
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation

SNYDER, Matthew J ; STENZEL, Timothy T ; BUCKLEY, Patrick J ; LAGOO, Anand S ; RIZZIERI, David A ; GASPARETTO, Cristina ; VREDENBURGH, James J ; CHAO, Nelson J ; GONG, Jerald Z

The American journal of surgical pathology, 2004-06, Vol.28 (6), p.794-800 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
8
Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma
Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma

Rizzieri, David A. ; Sand, Gregory J. ; McGaughey, Dean ; Moore, Joseph O. ; DeCastro, Carlos ; Chao, Nelson J. ; Vredenburgh, James J. ; Gasparetto, Cristina ; Long, Gwynn D. ; Anderson, Elizabeth ; Foster, Tracy ; Toaso, Bonnie ; Adams, Donna ; Niedzwiecki, Donna ; Gockerman, Jon P.

Cancer, 2004-06, Vol.100 (11), p.2408-2414 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
9
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma

Rizzieri, David A. ; Akabani, Gamal ; Zalutsky, Michael R. ; Coleman, R. Edward ; Metzler, Scott D. ; Bowsher, James E. ; Toaso, Bonnie ; Anderson, Elizabeth ; Lagoo, Anand ; Clayton, Steve ; Pegram, Charles N. ; Moore, Joseph O. ; Gockerman, Jon P. ; DeCastro, Carlos ; Gasparetto, Cristina ; Chao, Nelson J. ; Bigner, Darell D.

Blood, 2004-08, Vol.104 (3), p.642-648 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Preclinical Evaluation of Gemcitabine Combination Regimens for Application in Acute Myeloid Leukemia
Preclinical Evaluation of Gemcitabine Combination Regimens for Application in Acute Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preclinical Evaluation of Gemcitabine Combination Regimens for Application in Acute Myeloid Leukemia

SHANKS, Ryan H ; RIZZIERI, David A ; FLOWERS, James L ; COLVIN, O. Michael ; ADAMS, David J

Clinical cancer research, 2005-06, Vol.11 (11), p.4225-4233 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2001  (3)
  2. 2001Até2003  (3)
  3. 2004Até2006  (5)
  4. 2007Até2009  (7)
  5. Após 2009  (10)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.